4593 Healios KK
- 147
- -1-0.68%
Healios KK News
Healios Partners With AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen
Healios (TYO:4593) and AND Medical Group entered into a joint research agreement under which Healios will receive an upfront payment of 60 million yen for providing its regenerative medicine technolog
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP
Healios (TYO:4593) said it had acquired the assets of Athersys, which filed for Chapter 11 bankruptcy protection in January, for $2.25 million, according to a filing with the Tokyo Stock Exchange on T
Brands that moved the day before part 2 Graphico, Sakura KCS, Colombia, etc.
<コード>Stock name 29th closing price ⇒ NYK Line ＜9101＞ 4073-77 shipping stock compared to the previous day is being pushed by a soft trend. Capcom ＜9697＞ 2795-31JP Morgan Securities lowered its target stock price. Renesas Electronics＜6723＞ 2670.5 -13.5 TOPIX rebalance round also had a heavy increase in price. Mitsui Chemicals ＜4183＞ is it a rebalance sale with awareness of the weight of the value above 4331 -95? Cookpad ＜2193＞ 185 +50 large-scale self
Front market [stocks that have moved, stocks that have been created]
*Koito Seisakusho ＜7276＞ 2535 Ka - In anticipation of an improvement in supply and demand due to the announcement of a high level of share buybacks. *A new purchase is recommended at KOKUSAI ELECTRIC ＜6525＞ 4215 +370 Mizuho Securities. *Sega Sammy HD ＜6460＞ 2018 +151.5 Additional structural reform measures announced. *I-NET ＜9600＞ 2458 +183 The search for data center-related stocks is expanding. *Profit from sale of Fuji HD ＜4676＞ 1965 +136 investment securities
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data
Japan's benchmark index reached its highest in 52 weeks on Monday, with investors keeping their eyes peeled for the country's latest inflation data due on Tuesday. The Nikkei 225 added 0.4%, or 135.03
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation
Healios (TYO:4593) has proposed a reduction in capital stock and capital reserves, and appropriation of surplus, and will seek shareholders approval for the proposals on March 27, according to its fil
Jefferies Adjusts Healios K.K.'s Price Target at 140 Yen From 170 Yen, Keeps at Hold
02:40 AM EST, 02/20/2024 (MT Newswires) -- Jefferies Adjusts Healios K.K.'s Price Target at 140 Yen From 170 Yen, Keeps at Hold
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment
Healios (TYO:4593) and its subsidiary ProcellCure have initiated the process for a clinical trial by submitting a notification to the Pharmaceuticals and Medical Devices Agency (PMDA), according to it
Japanese Shares Finish Lower After Key Economic Data
Japanese shares ended slightly lower on Thursday after lackluster industrial production data, while a strong demand for exporter stocks and a positive sentiment over a weaker yen kept losses in check.
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal
Healios' (TYO:4593) clinical trial data on its treatment candidate for ischemic stroke were published in the JAMA Neurology journal, according to a Wednesday bourse filing. The Treasure study evaluate
Healios Secures LOI on Joint Research With AND
Healios K.K. (TYO:4593) and AND Medical Group have initiated a letter of intent for collaborative research, capitalizing on Healios' technology and culture supernatant, according to its filing on Wedn
Healios Steps In as Primary Bidder and Lender for Athersys's Asset Sale Amidst Bankruptcy
Healios K.K. (TYO:4593) has entered into an agreement to act as both the provider of debtor-in-possession financing and the initial "stalking horse" bidder in the sale of most of Athersys' assets, acc
Healios, Nobelpharma in Talks for Stem Cell Therapy Alliance for ARDS
Healios (TYO:4593) and its subsidiary ProcellCure entered into a letter of intent with Nobelpharma for an alliance focused on MultiStem, a somatic stem cell regenerative medicine therapy for the treat
Healios Invests in Arktus Therapeutics at Undisclosed Amount
Healios (TYO:4593) is strategically investing in Arktus Therapeutics through acquiring shares for an undisclosed amount, according to its filing last Friday. Healios, a regenerative medicine developme
Athersys Delisted From Nasdaq Risks Bankruptcy; Healios Remains Committed to Drug Development
Athersys, Healios' (TYO:4593)exclusive licensing partner for the development, manufacture, and marketing of cell therapy drug HLCM051 in global territories for Acute Respiratory Distress Syndrome (ARD
Jefferies Adjusts Healios' Price Target to 170 Yen From 280 Yen, Keeps at Hold
06:00 AM EDT, 10/12/2023 (MT Newswires) -- Jefferies Adjusts Healios' Price Target to 170 Yen From 280 Yen, Keeps at Hold
Healios Secures Exclusive License for Cell Therapy Drug, Expanding Treatment for Acute Respiratory Distress Syndrome
Healios (TYO:4593) has recently entered into an exclusive license agreement with Athersys, allowing the company to develop, manufacture, and sell the cell therapy drug HLCM051 for the treatment of acu
Analysis
Price Target
No Data
